All In Biotech

Drug Trial Radar · NCT06484192

Pain Control After Lumbar Spine Fusion

Randomized Controlled Trial of Postoperative Inpatient Ketorolac and Outpatient Naproxen Use Following Elective Lumbar Spine Fusion

Last checked: Nov 20, 2026Latest source record: Jul 3, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 428 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

428

Planned (sponsor's estimate)

Start

Jun 28, 2024

Primary completion

Jun 30, 2025

Study completion Jun 30, 2025

Sponsor

Lead sponsor
Rothman Institute OrthopaedicsAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 3, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this randomized controlled trial is to determine if patients who receive non-steroidal anti-inflammatory medications (NSAIDs) following elective lumbar spinal fusion have increased rates of symptomatic nonunion requiring revision spinal surgery at two-years follow-up, compared to those who do not receive NSAIDs.

Conditions

  • Spine Fusion
  • NSAID (Non-Steroidal Anti-Inflammatory Drug)
  • Postoperative Pain

Interventions

  • Naproxen 500 MgDrug

    participants will receive Naproxen (500 mg) to take for 7 days after surgery as needed

  • KetorolacDrug

    participants will receive Ketorolac (15 mg) immediately after surgery

  • OxyCODONE 5 mg Oral TabletDrug

    participants will receive OxyCODONE (5 mg) to take for 7 days after surgery as needed

  • Metaxalone 800 MGDrug

    participants will receive Metaxalone (800 MG) to take for 7 days after surgery as needed

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Fusion failureTime frame: 2 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Rothman Orthopaedic Institute

    Philadelphia, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.